Clinical trial
A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol
NCT01127568 is registered in ClinicalTrials.gov with Douglas Mental Health University Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol
- Lead sponsor
- Douglas Mental Health University Institute
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- February 28, 2010
- Completion date
- June 30, 2012
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.